Advancements in Understanding and Managing Deep Vein Thrombosis: A Contemporary Perspective


  • Mohd. Maruf Khan P.G. Scholar, Ilaj Bit Tadbeer H.S.Z.H. Government Autonomous Unani Medical College Bhopal, 462003,M.P.
  • Mehmooda Begum Professor, Ilaj Bit Tadbeer H.S.Z.H. Government Autonomous Unani Medical College Bhopal, 462003,M.P.
  • Arif Anees Reader, Ilaj Bit Tadbeer H.S.Z.H. Government Autonomous Unani Medical College Bhopal, 462003, M.P
  • Akanksha Mishra JRF, Centre of Excellence in Biotechnology, Madhya Pradesh Council of Science and Technology Bhopal, 462003, M.P.



Deep vein thrombosis, pathogenesis, pulmonary embolism


Deep vein thrombosis (DVT) refers to the formation of blood clots within the deep veins, typically affecting those in the pelvis or lower extremities, including the calf, femoral, and popliteal veins. DVT poses a significant global healthcare challenge due to its potential to cause life-threatening complications like pulmonary embolism. Recent years have seen substantial progress in comprehending the pathophysiology of DVT and in enhancing strategies for its prevention and management. This review article presents a contemporary viewpoint on the progress made in understanding and addressing DVT, focusing on advancements in epidemiology, risk factors, diagnosis, treatment, and preventive measures.


Download data is not yet available.


Caldeira D RFBMSA de ADGNPFFJCJ. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. . Heart . 2015;101:1204–11.

Yang SD DWYDSYZYFSZFD. Prevalence and risk factors of deep vein thrombosis in patients undergo-ing lumbar interbody fusion surgery: a single center cross-sectional study. . Medicine. 2015;94:2205.

Kesieme E KCJNIEDA. Deep vein thrombosis: a clinical review. . J Blood Med . 2011;2:59–69.

Al-Hameed F ADHSAQABEAEAMAKTAMMAHMBJSHMRFM. The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity. . Ann Thorac Med . 2015;10:3–15.

Musil D KMHJ. Venous thromboembolism-prevalence and risk factors in chronic venous disease patients. Phlebology . 2017;32:135–40.

Naess IA CSRPCSRFHJ. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–9.

Kyrle PA MEBCHMWAES. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–63.

van Ommen CH HHBHHRHHPM. Venous thromboembolism in childhood: a prospective twoyear registry in The Netherlands. . J Pediatr . 2001;139:678–81.

Bates SM GJS. Pregnancy and deep vein thrombosis. . Seminars in vascular medicine: Copyright© 2001 by Thieme Medical Publishers, Inc, 333 Seventh Avenue, New York, NY 10001, USA Tel:+ 1 (212) 584-4662 . 2001;97–104.

Gran OV SEBSJHSTHKWTRFFKHJB. Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism. . Haematologica. 2016;101:1046–53.

Ren W LZFZFQ. Analysis of risk factors for recurrence of deep venous thrombosis in lower extremities. . Med Sci Monit . 2014;20:199–204.

Topfer LA. Portable compression to prevent venous thromboembolism after hip and knee surgery: the activecare system. CADTH issues in emerging health technologies. . Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. 2016;146.

Whiting PS WDGGSVJAFOWSMK. Risk factors for deep venous thrombosis following orthopaedic trauma surgery: an analysis of 56,000 patients. . Arch Trauma Res. 206AD;5.

Murayama Y SIDYIRCTHMKMOMKSFHKT. A case of type 4 gastric cancer with peritoneal dissemination complicating venous thromboembolism treated effectively by combination of S-1 and warfarin. . Gan To Kagaku Ryoho . 2010;37:311–4.

Mukherjee SD SLMNWJPGLMLPC. Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients. . Pathophysiol Haemost Thromb . 2010;37:88–97.

Albagoush SA KSCR et al. StatPearls Publishing. Available from: 2023. Factor V Leiden Mutation.

Varga EA, Moll S. Prothrombin 20210 Mutation (Factor II Mutation). Circulation. 2004 Jul 20;110(3).

Soare AM, Popa C. Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses. J Med Life. 2010;3(4):412–5.

Baker D SBMGJPBGS. Complications and 30-day outcomes associated with venous thromboembolism in the pediatric orthopaedic surgical population. J Am Acad Orthop Surg . 2016;24:196–206.


Khan MM, Begum M, Anees A, Mishra A. Vein Unveiled: An Overview of Varicose Vein. World Journal of Current Medical and Pharmaceutical Research. 2024 Apr 30;47–52.

Müller-Bühl, Leutgeb, Engeser, Achankeng N, Szecsenyi, Laux. Varicose veins are a risk factor for deep venous thrombosis in general practice patients. Vasa. 2012 Aug 1;41(5):360–5.

Nicolaides AN KVFERJT. The origin of deep vein thrombosis: a venographic study. . Br J Radiol. 1971;44(525):653–63.

Brooks EG TWWM et al. Valves of the deep venous system: an overlooked risk factor. . Blood. 2009;114(6):1276–9.

Mitchell RN. Hemodynamic disorders, thromboembolic disease and shock. In Kumar V, Abbas AK, Fausto N Robbins and Cotran Pathologic Basis of Disease 7th ed India: Elsevier. 2009;133.

Kearon C. Natural history of venous thromboembolism. . Circulation. 2003;107:122–30.

Kahn SR SSLDAL. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. . J Gen Intern Med. 2000;15(6):425–9.

Oudega R MKHAW. Limited value of patient history and physical examination in diagnosing deep vein thrombosis in primary care. . Fam Pract. 2005;22(1):86–91.

Tapson VF CBDB et al. The Diagnostic Approach to Acute Venous Thromboembolism. Clinical Practice Guideline. American Thoracic Society. . Am J Respir Crit Care Med. 1990;160(3):1043–66.

Kahn SR. The clinical diagnosis of deep vein thrombosis: integrating incidence, risk factors and symptoms and signs. . Arch Intern Med. 1998;158(21):2315–23.

Ikard RW UKFR. Lower limb venous dynamics in pregnant women. . Surg Gynecol Obstet. 1971;132(3):483–8.

Van der Pol LM MATCCFHMKFA. Use of clinical prediction rules and D-dimer tests in the diagnostic management of pregnant patients with suspected acute pulmonary embolism. Blood Rev . 2017;31:31–6.

Wells PS ADRMFMKCDJKGMMLBKMJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. . N Engl J Med . 2003;349:1227–35.

Hargett CW TVF. Clinical probability and D-dimer testing: how should we use them in clinical practice? . Semin Respir Crit Care Med. 2008;29:15–24.

Pabinger I AC. Biomarkers and venous thromboembolism. . Arterioscler Thromb Vasc Biol . 2009;29:332–6.

Adam SS KNGCS. D-dimer antigen: current concepts and future prospects. . Blood . 2009;113:2878–87.

Lee N HDWACPCPJGAAYMLCTKLSSCCSSJJ. A major outbreak of severe acute respiratory syndrome in Hong Kong. . N Engl J Med. 2003;348:1986–94.

Chong LY FESGHS. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. . BMJ . 2012;344:3979.

Guyatt GH NSSSHJEMAECMVPEJMMLSGDCDSHJ. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. . Chest . 2012;53–70.

Cosmi B PG. D-dimer, oral anticoagulation, and venous thromboembolism recurrence. . Semin Vasc Med . 2005;5:365–70.

Howard LS HRJ. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. . Thorax . 2013;391–3.

Guyatt GH AECMGDSHJ. Executive summary: antithrombotic therapy and prevention of thrombo-sis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest . 2012;7–47.

Hofmann LV KWT. Catheter-directed thrombolysis for acute DVT. . Lancet . 2012;379:3–4.

Song K YYRZSYZMJQ. The preoperative incidence of deep vein thrombosis (DVT) and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures. . Arch Orthop Trauma Surg . 2016;136:1459–64.

Hirsh J LAY. How we diagnose and treat deep vein thrombosis. . Blood . 2002;99:3102–10.

Tovey C WS. Diagnosis, investigation, and management of deep vein thrombosis Clinical review. . BMJ . 2003;326:1180–4.

Zierler BK. Ultrasonography and diagnosis of venous thromboembolism. Circulation . 2004;109:9–14.

Kearon C GJHJ. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med . 1998;129(12):1044–9.

Tapson VF CBDB et al. The Diagnostic Approach to Acute Venous Thromboembolism. Clinical Practice Guideline. American Thoracic Society. . Am J Respir Crit Care Med. 1999;160(3):1043–66.

Rose SC ZWNB et al. Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology . 1990;175(3):639–44.

Kearon C JJNTGJS. Noninvasive diagnosis of deep vein thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. . Ann Intern Med . 1998;128(8):663–77.

Warwick D DOFW. International Surgical Thrombosis Forum. Orthopaedic thromboprophylaxis: limitations of current guidelines. . J Bone Joint Surg Br. 2008;90:127–32.

Wang KL CPLCPPLPSKCWCKHCLCLYWCYHYWYHCCLSYSJ. Management of venous thromboembolisms: part I. The consensus for deep vein thrombosis. Acta Cardiol Sin . 2016;32:1–22.

Hague A PARS. Role of compression therapy in pathophysiology of the venous system in lower limbs. . Surgeon. 2017;15:40–6.

McDonnell BP GKMAOHKCKBDJNÁF. Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism. . J Thromb Thrombolysis. 2017;43:105–11.

Smythe MA PJDPP. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. . J Thromb Thrombolysis. 2016;41:165–86.

Weitz JI HJSMM. New antithrombotic drugs: American college of chest physicians evidence-based clinical practice guidelines. . Chest . 2008;133:234–56.

Geerts WH BDPGHJSCLMCCW. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines. . Chest . 2008;133:381–453.

Basu S APKNKA. Lowdose maternal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy. . Birth Defects Res A Clin Mol Teratol. 2016;106:142–7.

Kearon C. Natural history of venous thromboembolism. . Circulation 2003; 107: I22-30.

Prandoni P BEMAGA. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004; 329: 484-485.

Kearon C AECAPPBHGSNMWPGMDFCMKSR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141 Suppl: e419S-e494S.

Frere C FD. Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients. . Thromb Haemost 2016; 116: 618-625.

Pan Y ZJMJSMZJWH. Retrievable inferior vena cava filters in trauma patients: prevalence and management of thrombus within the filter. . Eur J Vasc Endovasc Surg 2016; 52: 830-837.

Jaff MR MMASCMGNGSJJKJMATPVSWRZBK. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension a scientific statement from the American heart association. . Circulation 2011; 123: 1788- 1830.

Srinivas BC PSNCRBMCN. Catheter-directed thrombolysis along with mechanical thromboaspiration versus anticoagulation alone in the management of lower limb deep venous thrombosis-a comparative study. . Int J Angiol 2014; 23: 247-254.


36 Views | 11 Downloads

How to Cite

Khan, M. M., M. Begum, A. Anees, and A. Mishra. “Advancements in Understanding and Managing Deep Vein Thrombosis: A Contemporary Perspective”. International Journal of Pharmaceutics and Drug Analysis, vol. 12, no. 2, June 2024, pp. 29-37, doi:10.47957/ijpda.v12i2.587.



Review Articles
Share |